Johnson & Johnson, US government expands pact for next phase of Covid vaccine


Johnson & Johnson receives $ 454 million markup from the US government for the next phase of the Covid vaccine.

Johnson & Johnson and the U.S. Department of Health have expanded an agreement to support the next phase of research and development of COVID-19 vaccine candidates, the company said on Saturday.

Under the agreement, the company will provide approximately $ 604 million, and the Biomedical Advanced Research and Development Authority of the HHS division will provide approximately $ 454 million in support of the Phase 3 ENSEMBLE study, in Janssens COVID -19 study candidate will be assessed as a single dose in up to 60,000 volunteers worldwide, the company said in a statement


(Except for the headline, this story was not edited by GossipMantri staff and posted from a syndicated feed.)


Please enter your comment!
Please enter your name here